Radionuclide chelating compounds are provided for conjugation to targetting molecules such as proteins, peptides or antibodies. The resulting labelled targetting molecules may be used in diagnosis and therapy.
提供了放射性核素螯合化合物,可与靶向分子如蛋白质、肽或
抗体结合。所得到的标记靶向分子可用于诊断和治疗。